Optimization of the Simple One-Step Stool Processing Method to Diagnose Tuberculosis: Evaluation of Robustness and Stool Transport Conditions for Global Implementation.

Ethiopia TB diagnosis Xpert MTB/RIF (Ultra) assay children robustness simple one-step (SOS) stool method stool storage conditions tuberculosis

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
17 08 2023
Historique:
medline: 21 8 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

Stool is recommended as an alternative specimen for the diagnosis of tuberculosis (TB) in young children, as they cannot easily produce sputum. The Simple One-Step (SOS) stool processing method is a new and simple stool processing method for the detection of Mycobacterium tuberculosis (MTB) using Xpert MTB/RIF Ultra (Xpert-Ultra). We determined the robustness of the SOS stool processing method and stool specimen transport conditions in participants with confirmed TB. We processed stool using the standard protocol after simulated "transport," varying time, and temperature, and experimented with slightly modified processing steps. We included 2,963 Xpert-Ultra test results from 132 stool specimens of 47 TB participants, including 11 children aged <10 years. We compared Xpert-Ultra processing errors and MTB positivity rates between standard and modified procedures. Minor deviations from the standard SOS protocol did not significantly impact the Xpert-Ultra test outcomes. The rate of Xpert-Ultra processing errors significantly increased with noncold-chain transport, exposure of stool to sample reagent at room temperature or beyond 12 h, and adding >0.8 g of stool. We found that almost all steps in the current SOS stool processing method provide optimal Xpert-Ultra results but recommend an adjustment to use a wider range of stool amounts (0.3 to 0.8 g) than advised previously (0.8 g). With this adaptation, stool-based diagnosis of TB using the SOS stool processing method can be scaled-up.

Identifiants

pubmed: 37358407
doi: 10.1128/spectrum.01171-23
pmc: PMC10434014
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0117123

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Pediatric Infect Dis Soc. 2022 Oct 31;11(Supplement_3):S85-S93
pubmed: 36314546
J Clin Microbiol. 2010 Oct;48(10):3551-7
pubmed: 20720033
Stat Med. 1985 Jan-Mar;4(1):87-90
pubmed: 3992076
PLoS One. 2022 Oct 4;17(10):e0264103
pubmed: 36194578
Int J Tuberc Lung Dis. 2023 Jan 1;27(1):19-27
pubmed: 36853124
J Clin Microbiol. 2021 Jul 19;59(8):e0040621
pubmed: 34076469
BMJ Open. 2022 Jul 1;12(7):e058388
pubmed: 35777870
PLoS One. 2022 May 5;17(5):e0267661
pubmed: 35511771
Public Health Action. 2021 Jun 21;11(2):55-57
pubmed: 34159062

Auteurs

Bazezew Yenew (B)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Petra de Haas (P)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Getu Diriba (G)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Abebaw Kebede (A)

Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Bihil Sherefdin (B)

KNCV Tuberculosis Foundation Ethiopia, Addis Ababa, Ethiopia.

Yohannes Demissie (Y)

KNCV Tuberculosis Foundation Ethiopia, Addis Ababa, Ethiopia.

Ahmed Bedru (A)

KNCV Tuberculosis Foundation Ethiopia, Addis Ababa, Ethiopia.

Mamush Sahile (M)

KNCV Tuberculosis Foundation Ethiopia, Addis Ababa, Ethiopia.

Endale Mengesha (E)

KNCV Tuberculosis Foundation Ethiopia, Addis Ababa, Ethiopia.

Zewdu Gashu Dememew (ZG)

KNCV Tuberculosis Foundation Ethiopia, Addis Ababa, Ethiopia.

Ben Tegegn (B)

Addis Ababa City Health Bureau, Addis Ababa, Ethiopia.

Andrii Slyzkyi (A)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Misikir Amare (M)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Muluwork Getahun (M)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Saro Abdella (S)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Degu Jerene (D)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Edine Tiemersma (E)

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH